Fukuoka, Japan

Naoya Shindo

This inventor holds 1 USPTO granted patent. Top assignee: Rdiscovery, LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Naoya Shindo. Retrieved from https://idiyas.com/inventor/naoya-shindo-mdoxloo6

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Naoya Shindo: Innovator in Pharmaceutical Chemistry

Introduction

Naoya Shindo is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that inhibit complex formation in critical biological processes.

Latest Patents

Shindo holds a patent for "Drp1-filamin complex formation inhibitors." This patent includes compounds represented by a specific formula, along with their pharmacologically acceptable salts and solvates. The patent also covers pharmaceutical compositions and the uses of these compounds as prophylactic or therapeutic agents.

Career Highlights

Naoya Shindo is associated with Rdiscovery, LLC, where he applies his expertise in pharmaceutical research. His work focuses on innovative solutions that address complex biological challenges.

Collaborations

Shindo collaborates with esteemed colleagues, including Akio Ojida and Akiyuki Nishimura, to advance research in his field.

Conclusion

Naoya Shindo's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the industry. His work continues to pave the way for new therapeutic agents that can significantly impact healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…